These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31651906)

  • 1. Prolonged fever is not a reason to change antibiotics among patients with uncomplicated community-acquired acute pyelonephritis.
    Jang YR; Eom JS; Chung W; Cho YK
    Medicine (Baltimore); 2019 Oct; 98(43):e17720. PubMed ID: 31651906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of gentamicin for women with community-acquired uncomplicated acute pyelonephritis caused by gentamicin-susceptible or -resistant Escherichia coli: 10-year experience.
    Wie SH; Kim HW; Chang UI
    Microb Drug Resist; 2013 Aug; 19(4):316-22. PubMed ID: 23473263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli.
    Chang UI; Kim HW; Wie SH
    Korean J Intern Med; 2016 Jan; 31(1):145-55. PubMed ID: 26767868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of healthcare-associated infection in patients with community-onset acute pyelonephritis.
    Ha YE; Kang CI; Joo EJ; Park SY; Kang SJ; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
    Scand J Infect Dis; 2011 Aug; 43(8):587-95. PubMed ID: 21453206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of antimicrobial resistance in patients with obstructive pyelonephritis associated with ureteral stones and uncomplicated pyelonephritis.
    Jang YR; Won J; Han J; Chung W; Ahn SJ
    Medicine (Baltimore); 2022 Aug; 101(34):e30376. PubMed ID: 36042611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.
    Park SH; Choi SM; Chang YK; Lee DG; Cho SY; Lee HJ; Choi JH; Yoo JH
    J Antimicrob Chemother; 2014 Oct; 69(10):2848-56. PubMed ID: 24928854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change of antimicrobial susceptibility among Escherichia coli strains isolated from female patients with community-onset acute pyelonephritis.
    Lim SK; Park IW; Lee WG; Kim HK; Choi YH
    Yonsei Med J; 2012 Jan; 53(1):164-71. PubMed ID: 22187248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the clinical characteristics of elderly and non-elderly women with community-onset, non-obstructive acute pyelonephritis.
    Chang UI; Kim HW; Noh YS; Wie SH
    Korean J Intern Med; 2015 May; 30(3):372-83. PubMed ID: 25995668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae in elderly and non-elderly women.
    Wie SH; Kim HW; Chang UI
    Clin Microbiol Infect; 2014 Nov; 20(11):1211-8. PubMed ID: 24909648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
    Bosch-Nicolau P; Falcó V; Viñado B; Andreu A; Len O; Almirante B; Pigrau C
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis.
    Chang UI; Kim HW; Wie SH
    Yonsei Med J; 2015 Sep; 56(5):1266-73. PubMed ID: 26256969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
    Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F
    Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of piperacillin/tazobactam as a carbapenem-sparing antibiotic for treatment of acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.
    Yoon YK; Kim JH; Sohn JW; Yang KS; Kim MJ
    Int J Antimicrob Agents; 2017 Apr; 49(4):410-415. PubMed ID: 28263710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inappropriate empirical antibiotic therapy does not adversely affect the clinical outcomes of patients with acute pyelonephritis caused by extended-spectrum β-lactamase-producing Enterobacteriales.
    Kim SH; Oh S; Huh K; Cho SY; Kang CI; Chung DR; Peck KR
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):937-944. PubMed ID: 30868326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone resistance in uncomplicated acute pyelonephritis: epidemiology and clinical impact.
    Shin J; Kim J; Wie SH; Cho YK; Lim SK; Shin SY; Yeom JS; Lee JS; Kweon KT; Lee H; Cheong HJ; Park SH; Park DW; Ryu SY; Chung MH; Yoo S; Pai H
    Microb Drug Resist; 2012 Apr; 18(2):169-75. PubMed ID: 22400491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacteriological analysis of more than 600 febrile urinary infections managed in a community health network].
    Bruyère F; Vidoni M; Péan Y; Ruimy JA; Elfassi R
    Prog Urol; 2013 Sep; 23(10):890-8. PubMed ID: 24034802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonresponders: prolonged fever among infants with urinary tract infections.
    Bachur R
    Pediatrics; 2000 May; 105(5):E59. PubMed ID: 10799623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and microbiological characteristics of men with nonobstructive acute pyelonephritis: A multicenter retrospective observational study.
    Park MG; Cho SY; Kwon SY; Choi H; Lee JW
    Medicine (Baltimore); 2021 Oct; 100(40):e27386. PubMed ID: 34622842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing rates of extended-spectrum B-lactamase-producing Escherichia coli and Klebsiella pneumoniae in uncomplicated and complicated acute pyelonephritis and evaluation of empirical treatments based on culture results.
    Kayaaslan B; Oktay Z; Hasanoglu I; Kalem AK; Eser F; Ayhan M; Guner R
    Eur J Clin Microbiol Infect Dis; 2022 Mar; 41(3):421-430. PubMed ID: 34977996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of extended-spectrum β-lactamase production on treatment outcomes of acute pyelonephritis caused by escherichia coli in patients without health care-associated risk factors.
    Park SH; Choi SM; Lee DG; Cho SY; Lee HJ; Choi JK; Choi JH; Yoo JH
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1962-8. PubMed ID: 25583722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.